Hormonal Intensification Should Start at the Low-risk Stage in Metastatic Prostate Cancer
The treatment landscape for metastatic hormone-sensitive prostate cancer (mHSPC) has dramatically evolved. Monotherapy androgen deprivation therapy (ADT) with testosterone suppression alone is no longer the standard of care as multiple global phase 3 trials of different combinatorial strategies have...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2022-11-01
|
| coleção: | European Urology Open Science |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S2666168322007509 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|